Unknown

Dataset Information

0

Candesartan could ameliorate the COVID-19 cytokine storm.


ABSTRACT:

Background

Angiotensin receptor blockers (ARBs) reducing inflammation and protecting lung and brain function, could be of therapeutic efficacy in COVID-19 patients.

Methods

Using GSEA, we compared our previous transcriptome analysis of neurons injured by glutamate and treated with the ARB Candesartan (GSE67036) with transcriptional signatures from SARS-CoV-2 infected primary human bronchial epithelial cells (NHBE) and lung postmortem (GSE147507), PBMC and BALF samples (CRA002390) from COVID-19 patients.

Results

Hundreds of genes upregulated in SARS-CoV-2/COVID-19 transcriptomes were similarly upregulated by glutamate and normalized by Candesartan. Gene Ontology analysis revealed expression profiles with greatest significance and enrichment, including proinflammatory cytokine and chemokine activity, the NF-kappa B complex, alterations in innate and adaptive immunity, with many genes participating in the COVID-19 cytokine storm.

Conclusions

There are similar injury mechanisms in SARS-CoV-2 infection and neuronal injury, equally reduced by ARB treatment. This supports the hypothesis of a therapeutic role for ARBs, ameliorating the COVID-19 cytokine storm.

SUBMITTER: Elkahloun AG 

PROVIDER: S-EPMC7439834 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7242961 | biostudies-literature
2023-12-20 | GSE250520 | GEO
2020-12-01 | GSE149878 | GEO
| S-EPMC7734084 | biostudies-literature
| S-EPMC7360507 | biostudies-literature
| S-EPMC7527296 | biostudies-literature
| S-EPMC7204669 | biostudies-literature
| S-EPMC7299396 | biostudies-literature
| S-EPMC7524442 | biostudies-literature
| S-EPMC7832727 | biostudies-literature